Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.
D'Onofrio N, Sardu C, Trotta MC, Scisciola L, Turriziani F, Ferraraccio F, Panarese I, Petrella L, Fanelli M, Modugno P, Massetti M, Marfella LV, Sasso FC, Rizzo MR, Barbieri M, Furbatto F, Minicucci F, Mauro C, Federici M, Balestrieri ML, Paolisso G, Marfella R.
D'Onofrio N, et al. Among authors: mauro c.
Mol Metab. 2021 Dec;54:101337. doi: 10.1016/j.molmet.2021.101337. Epub 2021 Sep 7.
Mol Metab. 2021.
PMID: 34500107
Free PMC article.